Sep 30, 2021

Can B Corp. (OTCQB: CANB) Emerging Growth Conference 17 – September 29, 2021

Investors and Media:
(917) 658-7878


Sep 27, 2021

Can B Corp. Discusses Significant Delta-8 and Isomer Capacity Growth with The Stock Day Podcast

Investors and Media:

(917) 658-7878


Can B Corp Products, FDA Approved Medical Devices, Subsidiaries and Medical Team Among Topics Discussed by Company Director and CFO Stanley Teeple

Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a diversified health and wellness company, announces the release of CFO Stanley Teeple’s podcast interview by Stock Market Podcast.

In this podcast, Mr. Stanley Teeple discusses the current state of Can B, FDA products, Brands and Subsidiaries, along with their own R&D and production facility.

To access the audio interview, select your favorite provider listed here:


Apple Podcasts:


Google Podcasts:


Pocket Casts:




FDA Disclaimer
The statements contained in the Podcast have not been evaluated by the Food and Drug Administration. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.


Forward-Looking Statements

Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect,” and similar expressions identify such forward-looking statements. Expected, actual results, performance or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Investors and Media:

(917) 658-7878